Lista de obras -

A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster

artículo científico publicado en 2002

Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study

artículo científico publicado en 2021

Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).

artículo científico publicado en 2016

Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study

artículo científico publicado en 2013

Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families

artículo científico publicado en 2002

Association of Heart Rate With Troponin Levels Among Patients With Symptomatic Atrial Fibrillation

artículo científico publicado en 2020

C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients

artículo científico publicado en 2002

Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study

artículo científico publicado en 2014

Cardioversion in Acute Atrial Fibrillation Without Anticoagulation

artículo científico publicado en 2013

Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia.

artículo científico publicado en 2002

Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study

artículo científico publicado en 2017

Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q

artículo científico publicado en 2003

Comparison of GenFlex Tag Array and Pyrosequencing in SNP Genotyping ⬇️

artículo científico publicado el 1 de noviembre de 2003

Distribution of ischemic strokes in patients with atrial fibrillation: The FibStroke Study

scientific article published on 01 August 2019

Early Cardioversion for Acute Atrial Fibrillation in Low Stroke Risk Patients Is Safe Without Anticoagulation

scientific article published on 01 July 2020

Effect of 12-month statin therapy on antioxidant potential of LDL and serum antioxidant vitamin concentrations

artículo científico publicado en 2004

Effects of statin therapy on circulating conjugated dienes, a measure of LDL oxidation

artículo científico publicado en 2005

Etiology of Minor Troponin Elevations in Patients with Atrial Fibrillation at Emergency Department-Tropo-AF Study

scientific article published on 14 November 2019

How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?

artículo científico publicado en 2018

Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study

artículo científico publicado en 2021

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study

artículo científico publicado en 2017

Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.

artículo científico publicado en 2017

Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study

artículo científico publicado en 2016

Optimal timing for cardioversion in patients with atrial fibrillation

scientific article published on 23 July 2018

Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.

artículo científico publicado en 2016

Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).

artículo científico publicado en 2016

Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study.

artículo científico publicado en 2017

Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study

artículo científico publicado en 2016

Stroke as the First Manifestation of Atrial Fibrillation.

artículo científico publicado en 2016

Strokes after cardioversion of atrial fibrillation--The FibStroke study.

artículo científico publicado en 2015

Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes

artículo científico publicado en 2002

Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study

artículo científico publicado en 2013

Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications

artículo científico publicado en 2014

Traumatic and spontaneous intracranial hemorrhage in atrial fibrillation patients on warfarin

artículo científico publicado en 2018

Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study)

artículo científico publicado en 2018

Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study.

artículo científico publicado en 2015

Lista de obras de

A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster

Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study

Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).

Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study

Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families

Association of Heart Rate With Troponin Levels Among Patients With Symptomatic Atrial Fibrillation

C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients

Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study

Cardioversion in Acute Atrial Fibrillation Without Anticoagulation

Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia.

Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study

Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q

Comparison of GenFlex Tag Array and Pyrosequencing in SNP Genotyping ⬇️

Distribution of ischemic strokes in patients with atrial fibrillation: The FibStroke Study

Early Cardioversion for Acute Atrial Fibrillation in Low Stroke Risk Patients Is Safe Without Anticoagulation

Effect of 12-month statin therapy on antioxidant potential of LDL and serum antioxidant vitamin concentrations

Effects of statin therapy on circulating conjugated dienes, a measure of LDL oxidation

Etiology of Minor Troponin Elevations in Patients with Atrial Fibrillation at Emergency Department-Tropo-AF Study

How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?

Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study

Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.

Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study

Optimal timing for cardioversion in patients with atrial fibrillation

Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.

Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).

Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study.

Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study

Stroke as the First Manifestation of Atrial Fibrillation.

Strokes after cardioversion of atrial fibrillation--The FibStroke study.

Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes

Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study

Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications

Traumatic and spontaneous intracranial hemorrhage in atrial fibrillation patients on warfarin

Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study)

Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study.